23 episodes
The Life Extension Podcast - Technology & Magic, Society & Business drb
-
- Health & Fitness
-
-
5.0 • 1 Rating
-
The Life Extension Podcast discusses current efforts to significantly extend human live spans beyond normal medical progress. Science & technology, philosophy, politics, and business are together weaving a new posthuman mythology about our individual and social existence. Episodes present cutting-edge biomedical research, the status of various longevity therapies, and progress in replacing, enhancing, and possibly overcoming human biology with artificial intelligence. We are looking at underlying questions of aging and death, the way how science-based promises are often indistinguishable from magical practices, what it means to be human in this new technoscientific culture, and in what kind of society we are preparing to live in the future.
-
Ep 22 Current Status of Senolytics
Senolytic drugs are hoped to slow down and reverse age-related diseases by killing senescent cells. Zombie cells and their creepy behavior. Businesses and scientists are aiming to create life extension pills within a few years.
-
Ep 21 Calorie Restriction
About a method of life extension which really works. Benefits, challenges, and the supporting science. The medicalization of a cultural problem.
-
Ep 20 Posthumanism - Two Different Worlds
Apocalyptic fears and new utopian aspirations before the backdrop of digitalization, globalization, and urbanization. How environmentalism and transhumanism deliver opposed versions of a posthumanist worldview, and how they determine our political and social future.
-
Ep 19 Young Blood
Mythologies, symbolism, and gruesome practices involving young blood for rejuvenation. Surprisingly the practice works, but seems ethically unacceptable. The hunt for anti-aging therapies based on blood components.
-
Ep 18 Are We Living In A Simulation?
A debate about the nature of reality. The Matrix. Significance of the simulation hypothesis for transhumanism.
-
Ep 17 Current Status of Rapamycin
About the most promising drug against aging. Also about regulatory constraints and how they are being bypassed.